The widely-used diabetes drugs known as SGLT2 inhibitors have been linked to a rare form of flesh-eating genital infection that can result in disfigurement and death. Known as necrotizing fasciitis or Fournier's gangrene, this bacterial infection was the subject of a recent FDA diabetes drug warning. Previous FDA records show this flesh-eating bacterial infection harming only 6 individuals in 30 years, all of them men. In comparison, Type 2 diabetes drugs have been linked to 12 cases in only 5 years' time – 5 of them women. Patients who develop necrotizing fasciitis from SGLT2 inhibitors have required one or more surgeries. Some suffer from permanent disfigurement, and one died.
Thirteen different Type 2 diabetes drugs were included in the FDA diabetes drug infection warning, including products from multinational pharmaceutical conglomerates Janssen / Johnson & Johnson, AstraZeneca, Merck, and Eli Lilly. A brief look into these companies' track records shows consumers have little reason to trust these companies: J&J / Janssen has paid millions in settlements recently over talcum powder claims, for allegedly concealing a known ovarian cancer risk. AstraZeneca paid dearly for incidents of off-label marketing, the production of multiple dangerous drugs, and the fraudulent use of Medicaid funds. Merck paid approximately $6 billion in settlements and criminal fines related to its Vioxx painkiller. And Boehringer Ingelheim / Eli Lilly paid nearly $3 billion in criminal fines and payouts related to a decade-long coverup related to a schizophrenia drug. Bloomberg projects SGLT2 diabetes drug sales will reach $7 billion by 2020, and each of these companies is vying for a competitive edge in the market.
Now drug companies are facing serious questions about their prior knowledge of the risk for necrotizing fasciitis from diabetes drugs. Persons and the family members of persons who have suffered from the effects of flesh-eating genital infections from diabetes drugs are filing diabetes drug infection lawsuits against AstraZeneca, Janssen, Eli Lilly, and Merck. Filing a diabetes drug infection lawsuit is the only means individuals and families have to obtain the compensation they deserve for suffering, damage, medical expenses and loss related to the flesh-eating genital infection known as Fournier's gangrene or necrotizing fasciitis. In addition, filing a diabetes drug genital infection lawsuit claim is the best method for individual consumers to hold manufacturers accountable for the safety of its drugs.
Attorneys for diabetes drug infection lawsuits believe consumers who have developed the rare condition known as Fournier's gangrene may be eligible for significant compensation for the pain, suffering, medical expenses, and damage caused by diabetes drugs. This flesh-eating genital infection can worsen rapidly, require multiple surgeries, and result in disfigurement and death. Persons and family members of persons having suffered from necrotizing fasciitis are eligible for free, no-obligation case reviews with an attorney handling national diabetes drug infection lawsuit claims. Lawyers handling diabetes drug infection lawsuits for flesh-eating genital infections work on contingency, meaning you will never pay legal fees unless we win compensation for you. Read full diabetes drug infection lawsuit
information from attorneys handling claims from plaintiffs nationwide.
Our diabetes drug infection attorneys have a long track record of success against multinational pharmaceutical conglomerates, winning compensation for individuals and families harmed as a result of corporate greed and wrongdoing. When a billion-dollar drug corporation prioritized its bottom line over consumer safety, our diabetes drug genital infection lawyer group sees it as our mission to pursue justice no matter how complex the case. Our attorneys handling genital infection claims related to SGLT2 diabetes drugs help individuals and families recover the compensation they need and deserve, while holding companies accountable for consumer safety. Read full information from diabetes drug infection lawyers
for filing a claim against Eli Lilly/ Boehringer Ingelheim, AstraZeneca, Merck, and Janssen/J&J.
The FDA has identified a risk of flesh-eating genital infection from diabetes drugs known as SGLT2 inhibitors. This form of diabetes drug infection, known as Fournier's gangrene, tends to worsen rapidly and requires surgery. Some patients suffering from diabetes drug genital infections develop permanent disfigurement or life-threatening complications. Flesh-eating infections have been linked to the following diabetes drugs: canagliflozin (Invokana, Invokamet, Invokamet XR), dapagliflozin (Farxiga, Xigduo XR, Qtern), empagliflozin (Jardiance, Glyxambi, Synjardy, Synjardy XR), and ertugliflozinv (Steglatro, Segluromet, Stelujan). Persons and family members of persons who have suffered from flesh-eating genital infections as a result of taking diabetes drugs may be eligible for compensation through filing a diabetes drug infection lawsuit. Read full flesh-eating genital infection